A detailed history of King Luther Capital Management Corp transactions in Merck & Co., Inc. stock. As of the latest transaction made, King Luther Capital Management Corp holds 1,688,904 shares of MRK stock, worth $165 Million. This represents 0.83% of its overall portfolio holdings.

Number of Shares
1,688,904
Previous 1,644,109 2.72%
Holding current value
$165 Million
Previous $204 Million 5.77%
% of portfolio
0.83%
Previous 0.93%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$111.15 - $128.97 $4.98 Million - $5.78 Million
44,795 Added 2.72%
1,688,904 $192 Million
Q2 2024

Aug 12, 2024

SELL
$123.8 - $132.96 $592,506 - $636,346
-4,786 Reduced 0.29%
1,644,109 $204 Million
Q1 2024

May 13, 2024

SELL
$113.24 - $131.95 $607,192 - $707,515
-5,362 Reduced 0.32%
1,648,895 $218 Million
Q4 2023

Feb 09, 2024

SELL
$100.18 - $109.02 $5.39 Million - $5.86 Million
-53,763 Reduced 3.15%
1,654,257 $180 Million
Q3 2023

Nov 13, 2023

BUY
$102.95 - $114.33 $4.05 Million - $4.5 Million
39,354 Added 2.36%
1,708,020 $176 Million
Q2 2023

Aug 10, 2023

BUY
$108.61 - $118.38 $1.78 Million - $1.94 Million
16,390 Added 0.99%
1,668,666 $193 Million
Q1 2023

May 11, 2023

BUY
$102.94 - $114.86 $2.62 Million - $2.92 Million
25,429 Added 1.56%
1,652,276 $176 Million
Q4 2022

Feb 13, 2023

BUY
$87.44 - $112.11 $5.69 Million - $7.3 Million
65,074 Added 4.17%
1,626,847 $180 Million
Q3 2022

Nov 10, 2022

BUY
$84.53 - $94.96 $1.7 Million - $1.91 Million
20,115 Added 1.3%
1,561,773 $135 Million
Q2 2022

Aug 11, 2022

BUY
$83.49 - $94.64 $1.72 Million - $1.95 Million
20,630 Added 1.36%
1,541,658 $141 Million
Q1 2022

May 11, 2022

BUY
$73.51 - $82.4 $2.19 Million - $2.46 Million
29,850 Added 2.0%
1,521,028 $125 Million
Q4 2021

Feb 14, 2022

SELL
$72.28 - $90.54 $3.36 Million - $4.2 Million
-46,421 Reduced 3.02%
1,491,178 $114 Million
Q3 2021

Nov 10, 2021

SELL
$71.68 - $78.83 $5.65 Million - $6.21 Million
-78,807 Reduced 4.88%
1,537,599 $115 Million
Q2 2021

Aug 13, 2021

SELL
$70.31 - $77.77 $17.2 Million - $19 Million
-244,828 Reduced 13.15%
1,616,406 $126 Million
Q1 2021

May 12, 2021

SELL
$68.86 - $81.11 $5.41 Million - $6.37 Million
-78,520 Reduced 4.05%
1,861,234 $143 Million
Q4 2020

Feb 10, 2021

SELL
$71.77 - $79.65 $342,271 - $379,850
-4,769 Reduced 0.25%
1,939,754 $159 Million
Q3 2020

Nov 12, 2020

BUY
$73.18 - $82.95 $393,269 - $445,773
5,374 Added 0.28%
1,944,523 $161 Million
Q2 2020

Aug 12, 2020

BUY
$70.42 - $80.13 $1.67 Million - $1.9 Million
23,731 Added 1.24%
1,939,149 $150 Million
Q1 2020

May 13, 2020

BUY
$63.36 - $87.82 $457,712 - $634,411
7,224 Added 0.38%
1,915,418 $147 Million
Q4 2019

Feb 12, 2020

BUY
$77.58 - $87.54 $2.06 Million - $2.33 Million
26,578 Added 1.41%
1,908,194 $174 Million
Q3 2019

Nov 12, 2019

BUY
$76.08 - $82.93 $3.35 Million - $3.66 Million
44,095 Added 2.4%
1,881,616 $158 Million
Q2 2019

Aug 12, 2019

BUY
$69.84 - $81.59 $4.86 Million - $5.68 Million
69,637 Added 3.94%
1,837,521 $154 Million
Q1 2019

May 10, 2019

BUY
$69.58 - $79.36 $3.34 Million - $3.81 Million
48,049 Added 2.79%
1,767,884 $147 Million
Q4 2018

Feb 12, 2019

BUY
$65.24 - $75.71 $1.46 Million - $1.7 Million
22,395 Added 1.32%
1,719,835 $131 Million
Q3 2018

Nov 13, 2018

BUY
$57.69 - $67.84 $3.3 Million - $3.88 Million
57,167 Added 3.49%
1,697,440 $120 Million
Q2 2018

Aug 13, 2018

BUY
$50.83 - $59.72 $3.83 Million - $4.5 Million
75,322 Added 4.81%
1,640,273 $99.6 Million
Q1 2018

May 08, 2018

BUY
$50.96 - $59.23 $2.62 Million - $3.05 Million
51,441 Added 3.4%
1,564,951 $85.2 Million
Q4 2017

Feb 12, 2018

SELL
$51.62 - $61.64 $8.38 Million - $10 Million
-162,301 Reduced 9.68%
1,513,510 $85.2 Million
Q3 2017

Nov 13, 2017

BUY
$58.67 - $63.13 $98.3 Million - $106 Million
1,675,811
1,675,811 $107 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $247B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track King Luther Capital Management Corp Portfolio

Follow King Luther Capital Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of King Luther Capital Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on King Luther Capital Management Corp with notifications on news.